Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

90497

registered interest
date	03/09/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Cancer Drugs Fund
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, whether he authorised the recent increase in the Cancer Drug Fund annual budget; and whether (a) the Clinical Priorities Advisory Group and the Direct Commissioned Service Committee and (b) the Patient and Public Voice Assurance Group were consulted before that decision was taken.
tabling member constituency	Wells
tabling member printed	Tessa Munt
uin	208020
answer	answer is ministerial correction date of answer 10/09/2014 answer text <p> </p><p>My Rt hon Friend, the Secretary of State for Health, agreed that the size of the Cancer Drugs Fund would be increased to £280 million in both 2014-15 and 2015-16.</p><p> </p><p> </p><p> </p><p>We are advised by NHS England that the Clinical Priorities Advisory Group, the Direct Commissioned Service Committee and the Patient and Public Voice Assurance Group were not specifically consulted before this decision was taken.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 10/09/2014 12:33:03 answering member 4020 label Biography information for George Freeman
tabling member	4089 label Biography information for Tessa Munt

90319

registered interest
date	02/09/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Radiotherapy
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how many people in what age group have been funded for proton beam therapy in each of the last five years; and in what location each person was so treated.
tabling member constituency	Wells
tabling member printed	Tessa Munt
uin	207871
answer	answer is ministerial correction date of answer 05/09/2014 answer text <p> </p><p>The information is provided in the following table:</p><p> </p><p> </p><p> </p><table><tbody><tr><td><p>Year</p></td><td><p>Children</p></td><td><p>Adults</p></td><td><p>Total</p></td><td><p>Location</p></td></tr><tr><td><p>2009-10</p></td><td><p>8</p></td><td><p>12</p></td><td><p>20</p></td><td><p>France, USA and Switzerland</p></td></tr><tr><td><p>2010-11</p></td><td><p>30</p></td><td><p>20</p></td><td><p>50</p></td><td><p>USA (38 patients) and Switzerland (12)</p></td></tr><tr><td><p>2011-12</p></td><td><p>66</p></td><td><p>13</p></td><td><p>79</p></td><td><p>USA (majority of patients) and Switzerland</p></td></tr><tr><td><p>2012-13</p></td><td><p>83</p></td><td><p>16</p></td><td><p>99</p></td><td><p>USA (majority of patients) and Switzerland</p></td></tr><tr><td><p>2013-14</p></td><td><p>103*</p></td><td><p>21*</p></td><td><p>124*</p></td><td><p>All USA</p></td></tr></tbody></table><p> </p><p> </p><p> </p><p>*Figure includes treatments given and treatments due to be given following approval.</p><p> </p><p> </p><p> </p><p>It is not possible to provide a more detailed analysis of age group by location of treatment because it might be possible to identify individual patients from the data.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 05/09/2014 13:12:09 answering member 3918 label Biography information for Jane Ellison
tabling member	4089 label Biography information for Tessa Munt

79378

registered interest
date	22/07/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Radiotherapy
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, pursuant to the Answer of 21 July 2014, Official Report, column 1007W, on radiotherapy, when data relating to individual funding requests per indication for radiotherapy treatment made to NHS England and the number of such requests refused will be available from NHS England.
tabling member constituency	Wells
tabling member printed	Tessa Munt
uin	206964
answer	answer is ministerial correction date of answer 04/09/2014 answer text <p> </p><p>NHS England has advised us that it is aiming to complete its work on improving data collection for individual funding requests later this year. This will include information on requests received for radiotherapy treatments.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 04/09/2014 13:29:56 answering member 4020 label Biography information for George Freeman
tabling member	4089 label Biography information for Tessa Munt

79382

registered interest
date	22/07/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Radiotherapy
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, pursuant to the Answer of 21 July 2014, Official Report, column 1007W, on radiotherapy, in what respects University College Hospital London has failed to meet NHS England's service specifications for gamma knife services.
tabling member constituency	Wells
tabling member printed	Tessa Munt
uin	206965
answer	answer is ministerial correction date of answer 05/09/2014 answer text <p> </p><p>University College Hospitals London (UCHL) did not apply to be a contracted provider of gamma knife services for NHS England. For this reason it has not been formally assessed against the service specification. The gamma knife referred to is owned and operated by Queen’s Square Radiotherapy Centre (QSRC) Ltd, a private company wholly owned by Medical Equipment Solutions Limited, in premises owned by UCLH under a commercial agreement with UCLH.</p><p> </p><p> </p><p> </p><p>As the National Health Service was going through a major transition in 2013-14 it was decided at that time that there should be no new market entrants for stereotactic radiotherapy services. Therefore only existing commissioned providers were asked to identify the services that they considered themselves to be providing, and UCLH did not express an interest in respect to gamma knife treatment. QSRC Ltd is not an existing NHS England commissioned provider and therefore was not assessed against the service specification.</p><p> </p><p> </p><p>All patients need to be treated in accordance with the prescribed clinical pathways and in line with contractual agreements with providers. If providers treat outside the required contractual agreements then they do so at their own financial risk, and this is why NHS England instructs hospitals to this effect where no contractual arrangement is in place.</p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 206974 question first answered 05/09/2014 13:32:07 answering member 3918 label Biography information for Jane Ellison
tabling member	4089 label Biography information for Tessa Munt

79389

registered interest
date	22/07/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Radiotherapy
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, if he will investigate the reasons why NHS England is instructing hospitals with patients presenting as clinically urgent to treat such patients with innovative radiotherapy at the hospital's financial risk while it decides whether to fund the patient; and if he will issue guidelines on how hospitals which have followed that instruction will receive reimbursement for such expenditure if NHS England subsequently refuses to fund the treatment.
tabling member constituency	Wells
tabling member printed	Tessa Munt
uin	206974
answer	answer is ministerial correction date of answer 05/09/2014 answer text <p> </p><p>University College Hospitals London (UCHL) did not apply to be a contracted provider of gamma knife services for NHS England. For this reason it has not been formally assessed against the service specification. The gamma knife referred to is owned and operated by Queen’s Square Radiotherapy Centre (QSRC) Ltd, a private company wholly owned by Medical Equipment Solutions Limited, in premises owned by UCLH under a commercial agreement with UCLH.</p><p> </p><p> </p><p> </p><p>As the National Health Service was going through a major transition in 2013-14 it was decided at that time that there should be no new market entrants for stereotactic radiotherapy services. Therefore only existing commissioned providers were asked to identify the services that they considered themselves to be providing, and UCLH did not express an interest in respect to gamma knife treatment. QSRC Ltd is not an existing NHS England commissioned provider and therefore was not assessed against the service specification.</p><p> </p><p> </p><p>All patients need to be treated in accordance with the prescribed clinical pathways and in line with contractual agreements with providers. If providers treat outside the required contractual agreements then they do so at their own financial risk, and this is why NHS England instructs hospitals to this effect where no contractual arrangement is in place.</p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 206965 question first answered 05/09/2014 13:32:07 answering member 3918 label Biography information for Jane Ellison
tabling member	4089 label Biography information for Tessa Munt

78005

registered interest
date	15/07/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Radiotherapy
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, if he will request NHS England to authorise the use of Gamma Knife for NHS patients at University College Hospital London.
tabling member constituency	Wells
tabling member printed	Tessa Munt
uin	206028
answer	answer is ministerial correction date of answer 21/07/2014 answer text <p>NHS England is an independent arm’s length body and since 1 April 2013, it has been responsible for commissioning all radiotherapy services, including stereotactic radiosurgery. Gamma Knife treatment has been available to all patients who meet clinical criteria, without the need for individual funding requests, under NHS England’s national clinical commissioning policies for specialised services.</p><p> </p><p>University College London Hospitals is not contracted by NHS England, nor was it contracted by former primary care trusts, to provide Gamma Knife services. It is for this reason that National Health Service patients cannot normally be treated at this facility. Instead, NHS patients requiring Gamma Knife treatment should be treated by the Gamma Knife services commissioned by the NHS, that have been shown to meet NHS England service specifications. These can be accessed by patients in London without a waiting time, fully maintaining the continuity of their care and normally with the same consultant and clinical team.</p><p> </p><p>All patients need to be treated in accordance with the prescribed clinical pathways and in line with contractual agreements with providers.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 205954 question first answered 21/07/2014 16:30:36 answering member 3918 label Biography information for Jane Ellison
tabling member	4089 label Biography information for Tessa Munt

78009

registered interest
date	15/07/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Radiotherapy
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, for what reason none of the £42 million his Department has made available for increasing the use of radiotherapy is to be spent on treating cancer patients with Stereotactic Ablative Radiotherapy this year.
tabling member constituency	Wells
tabling member printed	Tessa Munt
uin	205834
answer	answer is ministerial correction date of answer 22/07/2014 answer text <p>In July 2011, the National Radiotherapy Implementation Group concluded that current evidence supports treatment withstereotactic ablative radiotherapy (SABR) for only a small number of patients. The evidence supports its use in the treatment of early stage lung cancers for patients who are unsuitable for surgery (approximately 1,000 per annum).</p><p> </p><p>NHS England recognises the positive clinical impact that its national policy on SABR for the treatment of early non-small cell lung cancer has had. It is currently examining the potential use of SABR in patients with oligometastatic disease – where a cancer is in the early stages of spreading.</p><p> </p><p>NHS England is also currently undertaking a review of stereotactic radiosurgery (SRS) and SABR for intracranial conditions to establish what the national demand is in line with its national clinical commissioning policies on SRS and SABR, and what the national capacity requirements are for this specialised treatment. Following the review it is planned that a final decision will be taken by the Specialised Commissioning Oversight Group in October 2014.</p><p> </p><p>Later this year, the Radiotherapy Clinical Reference Group will review its current policy position on SABR to assess whether there is new evidence to recommend its use on other conditions. It is important to ensure that treatments commissioned are supported by robust evidence of their benefit to patients.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 22/07/2014 13:47:28 answering member 3918 label Biography information for Jane Ellison
tabling member	4089 label Biography information for Tessa Munt

78013

registered interest
date	15/07/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Radiotherapy
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how many individual funding requests per indication were received by NHS England for radiotherapy treatment in the last financial year; and how many requests, per indication, were refused by NHS England.
tabling member constituency	Wells
tabling member printed	Tessa Munt
uin	205953
answer	answer is ministerial correction date of answer 21/07/2014 answer text <p>Since April 2013, radiotherapy treatment has been planned and paid for nationally by NHS England.</p><p> </p><p>NHS England has informed us that information on the number of individual funding requests made to NHS England is not currently available. NHS England is improving its data collection mechanisms and aims to improve availability of such information in the future.</p><p><br><br></p><p> </p> answering member constituency North Norfolk answering member printed Norman Lamb question first answered 21/07/2014 16:41:28 answering member 1439 label Biography information for Norman Lamb
tabling member	4089 label Biography information for Tessa Munt

78016

registered interest
date	15/07/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Radiotherapy
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, for what reasons NHS England is instructing hospitals with patients presenting as clinically urgent to treat such patients with innovative radiotherapy at the hospital's financial risk while it decides whether to fund the patient; and how hospitals which have followed that instruction receive reimbursement for that expenditure if NHS England subsequently refuses to fund the treatment.
tabling member constituency	Wells
tabling member printed	Tessa Munt
uin	205954
answer	answer is ministerial correction date of answer 21/07/2014 answer text <p>NHS England is an independent arm’s length body and since 1 April 2013, it has been responsible for commissioning all radiotherapy services, including stereotactic radiosurgery. Gamma Knife treatment has been available to all patients who meet clinical criteria, without the need for individual funding requests, under NHS England’s national clinical commissioning policies for specialised services.</p><p> </p><p>University College London Hospitals is not contracted by NHS England, nor was it contracted by former primary care trusts, to provide Gamma Knife services. It is for this reason that National Health Service patients cannot normally be treated at this facility. Instead, NHS patients requiring Gamma Knife treatment should be treated by the Gamma Knife services commissioned by the NHS, that have been shown to meet NHS England service specifications. These can be accessed by patients in London without a waiting time, fully maintaining the continuity of their care and normally with the same consultant and clinical team.</p><p> </p><p>All patients need to be treated in accordance with the prescribed clinical pathways and in line with contractual agreements with providers.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 206028 question first answered 21/07/2014 16:30:36 answering member 3918 label Biography information for Jane Ellison
tabling member	4089 label Biography information for Tessa Munt

78017

registered interest
date	15/07/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Monitor
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, to what extent NHS England is obliged to follow guidance issued by Monitor.
tabling member constituency	Wells
tabling member printed	Tessa Munt
uin	205780
answer	answer is ministerial correction date of answer 22/07/2014 answer text <p>It is the National Health Service (Procurement, Patient Choice and Competition) (No. 2) Regulations 2013 that place requirements on NHS England, including requirements as to good practice in relation to procurement.</p><p> </p><p>Enforcement of the procurement requirements by Monitor may only follow its investigation of a complaint that there has been a failure by a commissioner to comply with the requirements. Monitor has published guidance for NHS England and other commissioners of healthcare services which provides advice on how to comply with the regulations. Monitor expects to follow the interpretation of the regulations that it has set out in its guidance when exercising its enforcement powers under the regulations.</p><p> </p><p>In addition, to the extent that NHS England acts as a commissioner of services, it has a legal duty to have regard to guidance which Monitor publishes for commissioners of services which are designated as ‘commissioner requested services’. Before publishing the guidance or any revisions to it, Monitor must have first consulted NHS England.</p> answering member constituency Battersea answering member printed Jane Ellison question first answered 22/07/2014 16:03:53 answering member 3918 label Biography information for Jane Ellison
tabling member	4089 label Biography information for Tessa Munt